Inflection Biosciences Announces Participation at Upcoming Industry Conferences.
Dublin, Ireland, May 12th, 2020 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
top of page
News
Press Releases
Feb 19, 2020
Inflection Biosciences Announces Appointment of Shaun McNulty, Ph.D., as Chief Scientific Officer.
Dublin, Ireland, February 19th, 2020 Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of...
Feb 6, 2020
Inflection Biosciences Announces Appointment of Murray Yule, M.D., Ph.D., as Chief Medical Officer
(06 Feb 2020) Dublin, Ireland, February 6th, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the...
Jan 31, 2020
Inflection Biosciences to present at BIO CEO & Investor Conference 2020.
Dublin, Ireland, January 31, 2020 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
Nov 26, 2019
Inflection Biosciences Selected as Tech Tour Contest Finalist for 2019
Dublin, Ireland, November 26, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of...
Oct 30, 2019
Inflection Biosciences Announces Passing of Co-Founder and Board Member John Scanlan
Dublin, Ireland, October 30, 2019 – Inflection Biosciences Ltd today announced that John Scanlan, a co-founder and a member of its Board...
Sep 9, 2019
Inflection Biosciences Announces Pre-clinical Data to be Presented at IASLC 2019 World Conference.
Dublin, Ireland, September 9th, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of...
Aug 7, 2019
Inflection Biosciences Announces Publication of Positive Data for PIM/PI3K/mTOR Inhibitor
Dublin, Ireland, August 7, 2019 – Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer,...
Jul 18, 2019
Inflection Biosciences and AUM Biosciences announce Global License Agreement for PIM/PI3K/mTOR
Dublin, Ireland, 18 July 2019 – Inflection Biosciences (Inflection), a company developing innovative therapeutics for the treatment of...
Nov 28, 2018
Inflection Biosciences Announces Pre-clinical Data to be Presented at 2018 AACR Targeting PI3K/mTOR
Dublin, Ireland, November 28th, 2018 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...
bottom of page